Cargando…
Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy
Systemic vascular endothelial growth factor (VEGF) inhibitions can induce worsening hypertension, proteinuria and glomerular diseases of various types. These agents can also be used to treat ophthalmic diseases like proliferative diabetic retinopathy, diabetic macular edema, central retinal vein occ...
Autores principales: | Shye, Michael, Hanna, Ramy M, Patel, Sapna S, Tram-Tran, Ngoc, Hou, Jean, Mccannel, Collin, Khalid, Maham, Hanna, Mina, Abdelnour, Lama, Kurtz, Ira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769550/ https://www.ncbi.nlm.nih.gov/pubmed/33391740 http://dx.doi.org/10.1093/ckj/sfaa049 |
Ejemplares similares
-
Intravitreal bevacizumab-induced exacerbation of proteinuria in diabetic nephropathy, and amelioration by switching to ranibizumab
por: Hanna, Ramy M, et al.
Publicado: (2020) -
Review of intravitreal VEGF inhibitor toxicity and report of collapsing FSGS with TMA in a patient with age-related macular degeneration
por: Phadke, Gautam, et al.
Publicado: (2021) -
Proteinuria in COVID-19
por: Mohamed, Muner M B, et al.
Publicado: (2021) -
Development of Collapsing Focal and Segmental Glomerulosclerosis After Receiving Intravitreal Vascular Endothelial Growth Factor Blockade
por: Nobakht, Niloofar, et al.
Publicado: (2019) -
SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence
por: Kalay, Zeynepgul, et al.
Publicado: (2022)